Effects of aflatoxin B1 on the hepatic microsomal mixed function oxidase system during phenobarbital and benzo(a)pyrene treatment in chickens

Veterinary and Human Toxicology

Volumn 41, Issue 4, 1999, Pages 210-212

  Govindwar, S P ^a   Adav, S S ^a  

^a SHIVAJI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; AMINOPYRINE N DEMETHYLASE; BENZO[A]PYRENE; CYP 2B2; CYTOCHROME B5; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; DIMETHYL SULFOXIDE; ETHOXYRESORUFIN DEETHYLASE; MIXED FUNCTION OXIDASE; PENTOXYRESORUFIN DEALKYLASE; PHENOBARBITAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; SAFFLOWER OIL; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

AFLATOXICOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHICKEN; CONTROLLED STUDY; ELECTRON TRANSPORT; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; LIVER TOXICITY; NEWBORN; NONHUMAN;

AFLATOXIN B1; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CARCINOGENS; CHICKENS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INDUCTION; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; PHENOBARBITAL; STEROID HYDROXYLASES;

ANIMALIA; CARTHAMUS TINCTORIUS; GALLUS GALLUS;

EID: 0032784384     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kamdem L, Magdalou J, Siest G: Effect of aflatoxin B1 on the activity of drug metabolizing enzymes in rat liver. Toxicol Appl Pharmac 60: 570-578, 1981.
2. Plummer S, Boobis AR, Davis DS: Strain differences in the metabolic activation of aflatoxin B1 in the rat. Xenobiotica 17: 199-208, 1987.
3. Eaton DL, Gallagher DP: Mechanisms of aflatoxin carcinogensis. Ann Rev Pharm Toxic 34: 135-172, 1994.
4. Guengerich FP: Metabolic activation of carcinogens. Pharmac Ther 54: 17-61, 1992.
5. Massey TE, Stawart RK, Daniels JM et al: Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity. Proc Soc Exp Biol Med 208: 213-227, 1995.
6. Battista JR, Marnett LJ: Prostaglandin H-synthase dependent epoxidation of aflatoxin B1. Carcinogenesis 6: 1227-1229, 1985.
7. Liu L, Massey TE: Bioactivation of aflatoxin B1 by lipoxygenases, prostaglandin H synthases and cytochrome P450 monoxygenase in guinea pig tissues. Carcinogenesis 13: 533-539, 1992.
8. Datta K, Kulkarni AP: Oxidative metabolism of aflatoxin B1 by lipoxygenase purified from human term placenta and intrauterine conceptal tissue. Teratology 50: 311-317, 1994.
9. Halvorson MR, Phillips TD, Safe SH et al: Metabolism of aflatoxin B1 by rat hepatic microsomes induced by polyhalogenated biphenyl congeners. Appl Environ Microbiol 49: 882-886, 1985.
10. Gurtoo HL: Genetic expression of aflatoxin B1 metabolism: Effects of 3 methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the metabolism of aflatoxin B1 and B2 by various inbred strains of mice. Mol Pharmacol 18: 296-303, 1980.
11. Plummer S, Boobis AR, Davies DS: Is the activation of aflatoxin B1 catalyzed by the same form of cytochrome P450 as that 4-hydroxylating debrisoquin in rat and/or man? Arch Toxicol 58: 165-170, 1986.
12. Adav SS, Govindwar SP: Effects of aflatoxin B1 on liver microsomal enzymes in different strains of chickens. Comp Biochem Physiol 118C: 185-189, 1997.
13. 2+ sedimented microsomes from rat liver. Biochem Pharmac 21: 3249-3256, 1972.
14. Cornall AG, Bardawill CJ, David MM: Determination of serum proteins by means of the biuret reaction. J Biol Chem 177: 751-766, 1949.
15. Omura T, Sato R: The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239: 2370-2378, 1964.
16. Masters BSS, Williams CH, Kamin H: The preparation and properties of microsomal TPNH cytochrome c reductase from pig liver. In Estabrook RW, Pullman ME eds: Methods in Enzymology, Vol 10, Academic Press, New York: 565-573, 1967.
17. Schenkman JB, Remmer H, Estabrook RW: Special studies of drug interaction with hepatic microsomal cytochrome. Mol Pharmacol 3: 113-123, 1967.
18. Nash T: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55: 416-421, 1953.
19. Govindwar SP, Dalvi RR: Age dependent toxicity of acorn extract in young and old male rats. Vet Hum Toxicol 32: 23-26, 1990.
20. Fujii-Kuriyama Y, Mizukami Y, Kawajiri K et al: Primary structure of a cytochrome P450: Coding nucleotide sequence of phenobarbital inducible cytochrome P450 cDNA from rat liver. Proc Natl Acad Sci USA 79: 2793-2797, 1982.
21. Thomas PE, Reik LM, Ryan DE et al: Induction of two immunochemically related rat liver cytochrome P450 isozymes, cytochrome P450c and P450d, by structurally diverse xenobiotics. J Biol Chem 258: 4590-4598, 1983.
22. Varma RK, Kaushal R, Thomas GP et al: Evaluation of dimethyl sulfoxide as a solvent in pharmacological experiments. Ind J Exp Biol 25: 758-760, 1987.
23. Kodam KM, Adav SS, Govindwar SP: Effect of sulfamethazine on phenobarbital and benzo(a)pyrene induced hepatic microsomal mixed function oxidase system in rats. Toxicol Lett 87: 25-30, 1996.
24. Talalay P: The role of enzyme induction in protection against carcinogenesis. In Wattenberg L, Lipkin M, Boone CW et al eds. Cancer Chemoprevention , CRC Press, Boca Raton, FL: 469-478, 1992.